NCT00291655 Follow up Trial for Keppra (Levetiracetam) as Monotherapy in Patients With Newly Diagnosed Epilepsy Coming From N01175 (NCT00175903). Status COMPLETED Phase PHASE3
NCT00279617 Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks Status COMPLETED Phase PHASE3
NCT00265109 Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic Disorder Status COMPLETED Phase PHASE4
NCT00254657 Levetiracetam for Treatment of Pain Associated With Fibromyalgia Status COMPLETED Phase NA
NCT00252954 Levetiracetam in Chronic Neuropathic Pain Following Spinal Cord Injury Status COMPLETED Phase PHASE4
NCT00245713 Determine Effects of Adjunctive Levetiracetam on Sleep Architecture in Adults With Partial Onset Epilepsy. Status COMPLETED Phase PHASE4
NCT00242606 Lamotrigine Versus Levetiracetam in the Initial Monotherapy of Epilepsy Status COMPLETED Phase PHASE3
NCT00203216 A Clinical Study Examining the Safety and Effectiveness of a New Medication (Keppra®) for the Prevention of Migraine Headaches Status COMPLETED Phase NA
NCT00175955 Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia Status COMPLETED Phase PHASE2
NCT00175903 Levetiracetam Versus Standard Antiepileptic Drugs (Carbamazepine and Valproate) Used as Monotherapy in Patients With Newly Diagnosed Epilepsy Status COMPLETED Phase PHASE3
NCT00175890 A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures. Status COMPLETED Phase PHASE3
NCT00160654 Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy Status COMPLETED Phase PHASE4
NCT00160628 Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With Epilepsy Status COMPLETED Phase PHASE3
NCT00160615 Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method Status COMPLETED Phase PHASE3
NCT00160576 Levetiracetam Treatment in Adult Subjects With Parkinson's Disease Experiencing Troublesome Dyskinesias Status COMPLETED Phase PHASE2
NCT00160550 Study to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic Seizures Status COMPLETED Phase PHASE3